… %) included patients with atrial fibrillation treated with DOAC for … age for patients treated
with apixaban and rivaroxaban … , Italian and German studies compared with the patients in the …

… as an alternative to vitamin K antagonists (VKAs) and are … to describe the routine clinical
practice use of apixaban and other … atrial fibrillation in unselected patients in Germany. Results …

… type of OAC in routine clinical practice [11]. Moreover, VKA … quality methods for comparative
effectiveness research, dabigatran … compared to warfarin, while apixaban was not (Figure 4). …

… apixaban, rivaroxaban and edoxaban were at least as effective for stroke prevention in atrial
fibrillation … these dose transitions occur in clinical practice. Unlike the randomized trials for …

… Germany); all procedures were performed according to the principles of Good Clinical
Practice … by 1 event per 100 patient-years of treatment in patients with atrial fibrillation.[46] The …

… In particular, vitamin K antagonists were used more often than preferred … in clinical practice
in Germany. … Given their relative efficacy, safety and convenience, the European Society of …

… vitamin K antagonists such as warfarin as the standard of care for patients with atrial
fibrillation … in routine clinical practice. A recent meta-analysis of 10 studies, involving 148 909 …

… Atrial fibrillation patients with an acute coronary syndrome (ACS) or PCI were randomly
assigned to receive apixaban or a VKA and to receive aspirin or matching placebo for 6 months. …

… Vitamin K antagonists (VKA) have been the main treatment … We only included trials
published in English or German or … could be the different VKA prescribing practices; in the USA, …

… A relative reduction of the proportion of patients treated with low dosages was evident overtime
for dabigatran and rivaroxaban; whereas prescription of low dose apixaban … practice of …